Literature DB >> 10814882

Potential usage of thermosensitive liposomes for site-specific delivery of cytokines.

Y Yuyama1, M Tsujimoto, Y Fujimoto, N Oku.   

Abstract

Long-circulating liposomes reside long in the bloodstream, and transient swelling during phase transition of liposomes with hyper-osmotic internal aqueous phase causes release of macromolecules. Here we examined the applicability of long-circulating thermosensitive liposomes for delivery of tumor necrosis factor (TNF) by the heating of a local tumor-growing site after injection of TNF-loaded liposomes into tumor-bearing mice. Glucuronate modified thermosensitive liposomes with internal solution of two-fold higher osmotic pressure and sized through 200 nm-pore, released encapsulated [(131)I] human serum albumin at 42 degrees C in vitro and showed long-circulating character in vivo. Cytotoxic action of TNF encapsulated in long-circulating thermosensitive-liposomes (LCTS-liposomes) against L929 fibrosarcoma cells was enhanced at 42 degrees C in vitro. Furthermore, the tumor growth tended to be inhibited more by hyperthermia of mice bearing Meth A sarcoma than without heating after injection of TNF encapsulated in LCTS-liposomes. These results suggest that the cytokine can be released at the tumor site from the circulating CLTS-liposomes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10814882     DOI: 10.1016/s0304-3835(00)00410-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Nanoscale Drug Delivery and Hyperthermia: The Materials Design and Preclinical and Clinical Testing of Low Temperature-Sensitive Liposomes Used in Combination with Mild Hyperthermia in the Treatment of Local Cancer.

Authors:  Chelsea D Landon; Ji-Young Park; David Needham; Mark W Dewhirst
Journal:  Open Nanomed J       Date:  2011-01-01

2.  NANOMATERIALS FOR PROTEIN MEDIATED THERAPY AND DELIVERY.

Authors:  John N Barry; Alexey A Vertegel
Journal:  Nano Life       Date:  2013-12-27

Review 3.  Particle-mediated delivery of cytokines for immunotherapy.

Authors:  David A Christian; Christopher A Hunter
Journal:  Immunotherapy       Date:  2012-04       Impact factor: 4.196

Review 4.  Emerging nanotechnologies for cancer immunotherapy.

Authors:  Sourabh Shukla; Nicole F Steinmetz
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-04

Review 5.  Potential new methods for antiepileptic drug delivery.

Authors:  Robert S Fisher; Jet Ho
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

6.  Preparation and in vitro evaluation of doxorubicin-loaded Fe₃O₄ magnetic nanoparticles modified with biocompatible copolymers.

Authors:  Abolfazl Akbarzadeh; Haleh Mikaeili; Nosratollah Zarghami; Rahmati Mohammad; Amin Barkhordari; Soodabeh Davaran
Journal:  Int J Nanomedicine       Date:  2012-02-01

7.  Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine.

Authors:  Abolfazl Akbarzadeh; Mohamad Samiei; Soodabeh Davaran
Journal:  Nanoscale Res Lett       Date:  2012-02-21       Impact factor: 4.703

8.  Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line.

Authors:  Abolfazl Akbarzadeh; Mohammad Samiei; Sang Woo Joo; Maryam Anzaby; Younes Hanifehpour; Hamid Tayefi Nasrabadi; Soodabeh Davaran
Journal:  J Nanobiotechnology       Date:  2012-12-18       Impact factor: 10.435

9.  Molecular approaches to sarcoma therapy.

Authors:  R J Olsen; S R Tarantolo; S H Hinrichs
Journal:  Sarcoma       Date:  2002

10.  Ultrasound-Sensitive Liposomes for Triggered Macromolecular Drug Delivery: Formulation and In Vitro Characterization.

Authors:  Maria B C de Matos; Roel Deckers; Benjamin van Elburg; Guillaume Lajoinie; Bárbara S de Miranda; Michel Versluis; Raymond Schiffelers; Robbert J Kok
Journal:  Front Pharmacol       Date:  2019-12-05       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.